M. McTigue

发表

Investigation of the impurities found in methamphetamine synthesised from pseudoephedrine by reduction with hydriodic acid and red phosphorus.

J. R. Pearson, K. Windahl, M. McTigue, 1995, Forensic science international.

68Ga MPO Platelets in Human Pet Thrombus Imaging

R. Dalman, J. Atwood, E. Lang, 1994 .

Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens.

C. Meares, M. Mccall, D. Goodwin, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins

F. Torti, C. Meares, M. Mccall, 2004, European Journal of Nuclear Medicine.

Pretargeting: Improved Pharmacokinetics and Therapeutic Ratio

C. Meares, D. Goodwin, M. McTigue, 1997 .

Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.

D. Kukis, C. Meares, N. Watanabe, 1994, Cancer research.

Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.

C. Meares, M. Mccall, D. Goodwin, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent.

C. Meares, D. Goodwin, M. McTigue, 1994, Cancer research.

Pretargeted Immunoscintigraphy: Effectof HaptenValencyon MurineTumorUptake

C. Meares, M. Mccall, D. Goodwin, 1992 .

Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals.

C. Meares, M. Mccall, M. Stone, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake.

C. Meares, M. Mccall, D. Goodwin, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

PRETARGETED Y-90 THERAPY: PHARMACOKINETICS AND THERAPEUTIC RATIO IN BALB/C MICE WITH KHJJ MOUSE ADENOCARCINOMA USING MAB 2D12.5 AND Y-88 JANUS DOTA

C. Meares, D. Goodwin, M. McTigue, 1993 .

IMMUNOGENICITY OF (S) AND (R) ENANTIOMERS OF A MACROCYCLIC BIFUNCTIONAL CHELATING AGENT WITH IMMUNOCONJUGATES IN RABBITS

C. Meares, D. Goodwin, M. McTigue, 1992 .

Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.

C. Meares, M. Mccall, D. Goodwin, 1984, Analytical biochemistry.

LYMPHOSCINTIGRAPHY WITH IN‐111 LABELED MONOCLONAL ANTIBODIES: A4

H. Mcdevitt, C. Meares, M. Mccall, 1983 .

Antibodies against metal chelates

C. Meares, M. Stone, R. Bartholomew, 1985, Nature.

Rapid synthesis and quality control of 68Ga-labeled chelates for clinical use.

D. Goodwin, M. McTigue, C. Ransone, 1994, Nuclear Medicine and Biology.

Viability and biodistribution of 68Ga MPO‐labelled human platelets

R. Dalman, J. Atwood, E. Lang, 1993, Nuclear medicine communications.

Metal decomposition rates of 111In‐DPTA and EDTA conjugates of monoclonal antibodies in vivo

C. Meares, M. Mccall, D. Goodwin, 1986, Nuclear medicine communications.

Monoclonal antibody hapten radiopharmaceutical delivery

D. Goodwin, C. Mears, G. David, 1986, Nuclear medicine communications.